These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4674512)

  • 1. An experimental model of tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neural Transm; 1972; 33(3):235-46. PubMed ID: 4674512
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
    Klawans HL; Margolin DI; Dana N; Crosset P
    J Neurol Sci; 1975 Jul; 25(3):283-9. PubMed ID: 1171935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between daily dosage of chlorpromazine and subsequent supersensitivity.
    Klawans HL; Carvey P; Hitri A; Nausieda PA; Weiner WJ
    Adv Biochem Psychopharmacol; 1980; 24():569-72. PubMed ID: 7190763
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
    Klawans HL; Margolin DI
    Arch Gen Psychiatry; 1975 Jun; 32(6):725-32. PubMed ID: 1130936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
    Klawans HL; Crossett P; Dana N
    Adv Neurol; 1975; 9():105-12. PubMed ID: 1170714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of tardive dyskinesia: their use in the search for new treatment methods.
    Goetz CG; Klawans HL; Carvey P
    Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A; Cecchetti G; Ghezzi D; Samanin R
    Eur J Pharmacol; 1974 May; 26(2):179-83. PubMed ID: 4859224
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine receptor site sensitivity in hyperthyroid guinea pigs: a possible model of hyperthyroid chorea.
    Klawans HL; Goetz CH; Weiner WJ
    J Neural Transm; 1973; 34(3):187-93. PubMed ID: 4737273
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity.
    Klawans HL; D'amico DJ; Nausieda PA; Weiner WJ
    Psychopharmacology (Berl); 1977 Nov; 55(1):49-52. PubMed ID: 414261
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
    Weiner WJ; Goetz C; Westheimer R; Klawans HL
    J Neurol Sci; 1973 Dec; 20(4):373-9. PubMed ID: 4359068
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of O-methylation in dopamine-induced motor and behavioral phenomena.
    Furgeson MD; Dill RE; Dorris RL
    Brain Res; 1976 Mar; 105(1):163-7. PubMed ID: 3267
    [No Abstract]   [Full Text] [Related]  

  • 15. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
    Koller W; Curtin J; Fields J
    Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
    Rubovits R; Klawans HL
    Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of beta-/Tyr9/melanotropin-/9-18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine.
    Vécsei L; Telegdy G; Schally AV; Coy DH
    Neuropeptides; 1982 Dec; 3(2):91-6. PubMed ID: 6891751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig.
    Eibergen RD; Carlson KR
    Psychopharmacology (Berl); 1976 Jul; 48(2):139-46. PubMed ID: 826925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intracisternally administered adenosine and inosine on apomorphine- and amphetamine-induced stereotyped behaviour in rats.
    Singh J
    Indian J Physiol Pharmacol; 1990 Jan; 34(1):45-7. PubMed ID: 2361724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.